CN106727671A - A kind of glycosaminoglycan quaternary ammonium salt solution with antibacterial activity and preparation method thereof - Google Patents

A kind of glycosaminoglycan quaternary ammonium salt solution with antibacterial activity and preparation method thereof Download PDF

Info

Publication number
CN106727671A
CN106727671A CN201710009683.0A CN201710009683A CN106727671A CN 106727671 A CN106727671 A CN 106727671A CN 201710009683 A CN201710009683 A CN 201710009683A CN 106727671 A CN106727671 A CN 106727671A
Authority
CN
China
Prior art keywords
parts
hour
ammonium salt
glycosaminoglycan
quaternary ammonium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710009683.0A
Other languages
Chinese (zh)
Other versions
CN106727671B (en
Inventor
孙法
孙威
武兵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JILIN JUNTONGXING BIOTECHNOLOGY Co Ltd
Original Assignee
JILIN JUNTONGXING BIOTECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JILIN JUNTONGXING BIOTECHNOLOGY Co Ltd filed Critical JILIN JUNTONGXING BIOTECHNOLOGY Co Ltd
Priority to CN201710009683.0A priority Critical patent/CN106727671B/en
Publication of CN106727671A publication Critical patent/CN106727671A/en
Application granted granted Critical
Publication of CN106727671B publication Critical patent/CN106727671B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Abstract

The invention discloses a kind of glycosaminoglycan quaternary ammonium salt solution with antibacterial activity, it is characterized in that with 2,3 epoxypropyltrimethylchloride chlorides, glycosaminoglycan are raw material, in the reaction of high-pressure magnetic reactor, high substituted degree glycosaminoglycan quaternary ammonium salt is generated under specified conditions, antibacterial activity strengthens, and good stability is with short production cycle, low production cost, excellent, raising evident in efficacy is acted on, good result is achieved.

Description

A kind of glycosaminoglycan quaternary ammonium salt solution with antibacterial activity and preparation method thereof
Technical field
The present invention relates to field of medicaments, and in particular to a kind of glycosaminoglycan quaternary ammonium salt solution and its system with antibacterial activity Preparation Method.
Background technology
Prepared by glycosaminoglycan quaternary ammonium salt is chemically modified glycosaminoglycan glycosaminoglycan higher derivative, with antibacterial Performance, nontoxic, good biocompatibility is biodegradable, and its antibacterial activity is related to substitution value.Amino prepared by prior art is more Sugared quaternary ammonium salt substitution value is low, and antibacterial activity is weak, and the production cycle is long, and production cost is high, and stability is poor, it is impossible to satisfactory.
The content of the invention
The present invention is, according to chemical synthesis experience for many years, with reference to modern chemical industry synthetic technology, there is provided a kind of high substituted degree, to resist Bacterium activity is strong, and good stability is with short production cycle, low production cost, acts on excellent glycosaminoglycan quaternary ammonium salt solution.
Invention embodiment is as follows:
50 parts of 2,3 epoxypropyltrimethylchloride chloride is taken, is put in reactor, add 100 parts of 30% sodium hydroxide solution, stirring 1 is small When, it is made 2,3 epoxypropyltrimethylchloride chloride solution;8 parts of glycosaminoglycan is taken, is put in high-pressure magnetic reactor, add isopropyl 40 parts of alcohol, 1 part of Magnesiumaluminumsilicate, 1 part of calcium chloride, stir 1 hour, add above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, choosing Magnetic force power 1600W is selected, 75~85 DEG C are warming up to, reacted 1 hour, add 10% hydrochloric acid to adjust pH value to 7.0, suction filtration, filter cake is added 100 parts of absolute ethyl alcohol, reacts 1 hour, is purified with the dialysis membrane that molecular cut off is 300000, and product substitution value is 99%, rotation Concentration, plus purified water is made the glycosaminoglycan quaternary ammonium salt solution that mass concentration is 0.010%~10%.
The raw material standards that the embodiment above is previously mentioned is as follows:
2,3 epoxypropyltrimethylchloride chlorides:No. CAS:3033-77-0;
NaOH:The Chinese Pharmacopoeia ministerial standard of version four in 2015;
Isopropanol:The Chinese Pharmacopoeia ministerial standard of version four in 2015;
Magnesiumaluminumsilicate:The Chinese Pharmacopoeia ministerial standard of version four in 2015;
Calcium chloride:The Chinese Pharmacopoeia ministerial standard of version four in 2015;Hydrochloric acid:The Chinese Pharmacopoeia ministerial standard of version four in 2015;
Absolute ethyl alcohol:The Chinese Pharmacopoeia ministerial standard of version four in 2015;
Glycosaminoglycan:The straight-chain polysaccharide of the disaccharide unit repeated polymerization that amidohexose is constituted with uronic acid, its amidohexose It is often 2-Acetamido-2-deoxy-D-glucose base N- acetylamino galactosamines, uronic acid is usually glucuronic acid:Inner controlling standard of enterprise.
Raw material used in the present invention can be commercially available from pharmaceuticals, as long as meet standard to can be used to implement this Scheme of the invention.
The key equipment that foregoing invention embodiment is previously mentioned is as follows:
High-pressure magnetic reactor:1000~2000W of power;
(Typical production producer:The global chemical machinery Co., Ltd in Weihai)
Above equipment Market has sale, however it is not limited to listed typical production producer, as long as technical indicator can reach requirement, Can be used to realize the present invention.
" part " described in foregoing invention scheme refers to weight portion.
When reaction temperature and pressure are not indicated in foregoing invention scheme, all refer to normal temperature, normal pressure.
Term used is pharmacy proprietary term in foregoing invention scheme, unless otherwise specified, all defers to Chinese Pharmacopoeia and state Food and medicine Surveillance Authority of family related specifications.
Specific embodiment
Specific embodiment of the invention 1
2,3 epoxypropyltrimethylchloride chloride 50g are taken, is put in reactor, add 30% sodium hydroxide solution 100g, stirring 1 is small When, it is made 2,3 epoxypropyltrimethylchloride chloride solution;Glycosaminoglycan 8g is taken, is put in high-pressure magnetic reactor, add isopropanol 40g, Magnesiumaluminumsilicate 1g, calcium chloride 1g, stir 1 hour, add above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, select magnetic Activity of force 1600W, is warming up to 75~85 DEG C, reacts 1 hour, adds 10% hydrochloric acid to adjust pH value to 7.0, and suction filtration, filter cake adds anhydrous Ethanol 100g, reacts 1 hour, is purified with the dialysis membrane that molecular cut off is 300000, and spin concentration, plus purified water is made quality Concentration is 0.01% glycosaminoglycan quaternary ammonium salt solution.
Specific embodiment of the invention 2
2,3 epoxypropyltrimethylchloride chloride 50g are taken, is put in reactor, add 30% sodium hydroxide solution 100g, stirring 1 is small When, it is made 2,3 epoxypropyltrimethylchloride chloride solution;Glycosaminoglycan 8g is taken, is put in high-pressure magnetic reactor, add isopropanol 40g, Magnesiumaluminumsilicate 1g, calcium chloride 1g, stir 1 hour, add above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, select magnetic Activity of force 1600W, is warming up to 75~85 DEG C, reacts 1 hour, adds 10% hydrochloric acid to adjust pH value to 7.0, and suction filtration, filter cake adds anhydrous Ethanol 100g, reacts 1 hour, is purified with the dialysis membrane that molecular cut off is 300000, and spin concentration, plus purified water is made quality The glycosaminoglycan quaternary ammonium salt solution of concentration 0.1%, pours into feeder, is made glycosaminoglycan quaternary ammonium salt nasal wash,.
Specific embodiment of the invention 3
2,3 epoxypropyltrimethylchloride chloride 50g are taken, is put in reactor, add 30% sodium hydroxide solution 100g, stirring 1 is small When, it is made 2,3 epoxypropyltrimethylchloride chloride solution;Glycosaminoglycan 8g is taken, is put in high-pressure magnetic reactor, add isopropanol 40g, Magnesiumaluminumsilicate 1g, calcium chloride 1g, stir 1 hour, add above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, select magnetic Activity of force 1600W, is warming up to 75~85 DEG C, reacts 1 hour, adds 10% hydrochloric acid to adjust pH value to 7.0, and suction filtration, filter cake adds anhydrous Ethanol 100g, reacts 1 hour, is purified with the dialysis membrane that molecular cut off is 300000, and product substitution value is 99%, spin concentration, Plus purified water is made the glycosaminoglycan quaternary ammonium salt solution that mass concentration is 0.05%, pours into feeder, is made glycosaminoglycan quaternary ammonium Salt oral cavity flushing washing lotion.
Specific embodiment of the invention 4
2,3 epoxypropyltrimethylchloride chloride 50g are taken, is put in reactor, add 30% sodium hydroxide solution 100g, stirring 1 is small When, it is made 2,3 epoxypropyltrimethylchloride chloride solution;Glycosaminoglycan 8g is taken, is put in high-pressure magnetic reactor, add isopropanol 40g, Magnesiumaluminumsilicate 1g, calcium chloride 1g, stir 1 hour, add above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, select magnetic Activity of force 1600W, is warming up to 75~85 DEG C, reacts 1 hour, adds 10% hydrochloric acid to adjust pH value to 7.0, and suction filtration, filter cake adds anhydrous Ethanol 100g, reacts 1 hour, is purified with the dialysis membrane that molecular cut off is 300000, and spin concentration, plus purified water is made quality Concentration is 0.10% glycosaminoglycan quaternary ammonium salt solution, is poured into feeder, is made glycosaminoglycan quaternary ammonium salt vaginal douche.
Specific embodiment of the invention 5
2,3 epoxypropyltrimethylchloride chloride 50g are taken, is put in reactor, add 30% sodium hydroxide solution 100g, stirring 1 is small When, it is made 2,3 epoxypropyltrimethylchloride chloride solution;Glycosaminoglycan 8g is taken, is put in high-pressure magnetic reactor, add isopropanol 40g, Magnesiumaluminumsilicate 1g, calcium chloride 1g, stir 1 hour, add above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, select magnetic Activity of force 1600W, is warming up to 75~85 DEG C, reacts 1 hour, adds 10% hydrochloric acid to adjust pH value to 7.0, and suction filtration, filter cake adds anhydrous Ethanol 100g, reacts 1 hour, is purified with the dialysis membrane that molecular cut off is 300000, and spin concentration, plus purified water is made quality The glycosaminoglycan quaternary ammonium salt gel of concentration 10.0%, pours into feeder, is made glycosaminoglycan quaternary ammonium salt woman with filling gel.
Specific embodiment of the invention 6
2,3 epoxypropyltrimethylchloride chloride 50g are taken, is put in reactor, add 30% sodium hydroxide solution 100g, stirring 1 is small When, it is made 2,3 epoxypropyltrimethylchloride chloride solution;Glycosaminoglycan 8g is taken, is put in high-pressure magnetic reactor, add isopropanol 40g, Magnesiumaluminumsilicate 1g, calcium chloride 1g, stir 1 hour, add above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, select magnetic Activity of force 1600W, is warming up to 75~85 DEG C, reacts 1 hour, adds 10% hydrochloric acid to adjust pH value to 7.0, and suction filtration, filter cake adds anhydrous Ethanol 100g, reacts 1 hour, is purified with the dialysis membrane that molecular cut off is 300000, and spin concentration, plus purified water is made quality Concentration is 10% glycosaminoglycan quaternary ammonium salt gel, in pouring into feeder, is made glycosaminoglycan quaternary ammonium salt and disappears hemorrhoid gel.
Specific embodiment of the invention 7
2,3 epoxypropyltrimethylchloride chloride 50g are taken, is put in reactor, add 30% sodium hydroxide solution 100g, stirring 1 is small When, it is made 2,3 epoxypropyltrimethylchloride chloride solution;Glycosaminoglycan 8g is taken, is put in high-pressure magnetic reactor, add isopropanol 40g, Magnesiumaluminumsilicate 1g, calcium chloride 1g, stir 1 hour, add above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, select magnetic Activity of force 1600W, is warming up to 75~85 DEG C, reacts 1 hour, adds 10% hydrochloric acid to adjust pH value to 7.0, and suction filtration, filter cake adds anhydrous Ethanol 100g, reacts 1 hour, is purified with the dialysis membrane that molecular cut off is 300000, and spin concentration, plus purified water is made quality Concentration is 0.10% glycosaminoglycan quaternary ammonium salt solution, is poured into feeder, is made glycosaminoglycan quaternary ammonium salt skin washing solutions.
Specific embodiment of the invention 8
2,3 epoxypropyltrimethylchloride chloride 50g are taken, is put in reactor, add 30% sodium hydroxide solution 100g, stirring 1 is small When, it is made 2,3 epoxypropyltrimethylchloride chloride solution;Glycosaminoglycan 8g is taken, is put in high-pressure magnetic reactor, add isopropanol 40g, Magnesiumaluminumsilicate 1g, calcium chloride 1g, stir 1 hour, add above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, select magnetic Activity of force 1600W, is warming up to 75~85 DEG C, reacts 1 hour, adds 10% hydrochloric acid to adjust pH value to 7.0, and suction filtration, filter cake adds anhydrous Ethanol 100g, reacts 1 hour, is purified with the dialysis membrane that molecular cut off is 300000, and spin concentration, plus purified water is made quality Concentration is 0.3% glycosaminoglycan quaternary ammonium salt solution, is poured into feeder, is made glycosaminoglycan quaternary ammonium salt flushing liquor.
Specific embodiment of the invention 9
2,3 epoxypropyltrimethylchloride chloride 50g are taken, is put in reactor, add 30% sodium hydroxide solution 100g, stirring 1 is small When, it is made 2,3 epoxypropyltrimethylchloride chloride solution;Glycosaminoglycan 8g is taken, is put in high-pressure magnetic reactor, add isopropanol 40g, Magnesiumaluminumsilicate 1g, calcium chloride 1g, stir 1 hour, add above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, select magnetic Activity of force 1600W, is warming up to 75~85 DEG C, reacts 1 hour, adds 10% hydrochloric acid to adjust pH value to 7.0, and suction filtration, filter cake adds anhydrous Ethanol 100g, reacts 1 hour, is purified with the dialysis membrane that molecular cut off is 300000, and spin concentration, plus purified water is made quality Concentration is 0.02% glycosaminoglycan quaternary ammonium salt solution, is poured into feeder, is made the clean intestinal juice of glycosaminoglycan quaternary ammonium salt.
Actual effect of the invention is investigated with embodiment below:
(One)Glycosaminoglycan quaternary ammonium salt solution substitution value obtained in embodiment 1 is determined.
1 assay method
According to potentiometric titration(Chinese Pharmacopoeia version in 2015 four 0701)Determine, the sample 100ml of Example 1, in putting conical flask, Titrated with the AgNO3 titrating solutions of 0.017mol/L, meter record AgNO3 consumption volumes calculate glycosaminoglycan quaternary ammonium salt substitution value.
The glycosaminoglycan quaternary ammonium salt substitution value of table 1
Name of product Substitution value
Glycosaminoglycan quaternary ammonium salt prepared by embodiment 1 0.99
Data above shows:The substitution value of glycosaminoglycan quaternary ammonium salt solution prepared by the present invention is 0.99.
(Two)Glycosaminoglycan quaternary ammonium salt bacteriostatic activity obtained in embodiment 1.
The glycosaminoglycan quaternary ammonium salt bacteriostatic activity of table 2 is contrasted
Data above shows:Glycosaminoglycan quaternary ammonium salt prepared by the present invention is more antibacterial than glycosaminoglycan quaternary ammonium salt prepared by prior art Activity is significantly increased, p < 0.01.
(Three)Glycosaminoglycan quaternary ammonium salt solution stability obtained in embodiment 1.
Glycosaminoglycan quaternary ammonium salt solution term of validity contrast table obtained in the embodiment 1 of table 3
Data above shows:Glycosaminoglycan quaternary ammonium salt prepared by the present invention is more stable than glycosaminoglycan quaternary ammonium salt prepared by prior art Property is significantly increased, p < 0.01.
(Four)The obtained glycosaminoglycan quaternary ammonium salt production cycle of the invention
The production cycle of table 4 contrasts
Data above shows:The present invention prepares the glycosaminoglycan quaternary ammonium salt production cycle than glycosaminoglycan quaternary ammonium prepared by prior art The salt production cycle significantly shortens, p < 0.01.
(Five)Obtained glycosaminoglycan quaternary ammonium salt production cost of the invention
The production cost of table 5 is contrasted
Data above shows:The present invention prepares glycosaminoglycan quaternary ammonium salt production cost than glycosaminoglycan quaternary ammonium prepared by prior art Salt production cost is significantly reduced, p < 0.01.
(Six)Glycosaminoglycan quaternary ammonium salt vaginal bioadhesive long acting antibiotic gel clinical observation on the therapeutic effect obtained in embodiment 5
1 case scenario
Statistics outpatient service and inpatient, observe vaginitis patient 60, average age 32 years old altogether.Patient has different degrees of the moon The symptoms such as road itch, abnormal leucorrhea, private parts peculiar smell, clinical diagnosis is vaginitis.Patient is randomly divided into two groups, test group is used Glycosaminoglycan quaternary ammonium salt vaginal bioadhesive long acting antibiotic gel obtained in embodiment 5, control group uses commercially available nano silver antimicrobial gel.
2 efficacy assessment standards
Cure:Symptom, sign disappear or basic disappearance, and integration reduces >=95%.
It is effective:Symptom, sign are obviously improved, and integration reduces >=70%.
Effectively:Symptom, sign take a favorable turn, and integration reduces >=30%.
It is invalid:Symptom, sign are not improved or aggravate, and integration reduces < 30%.
Computing formula:[(Integrated after integration-treatment before treatment)Integration before ÷ treatments] × 100%.
3 clinical observation results
The glycosaminoglycan quaternary ammonium salt vaginal bioadhesive long acting antibiotic gel clinical efficacy contrast table of 6 embodiment of table 5
Data above shows:Glycosaminoglycan quaternary ammonium salt vaginal bioadhesive long acting antibiotic gel prepared by the present invention is evident in efficacy higher than city Sell nano silver antimicrobial gel, p < 0.01.
(Seven)Glycosaminoglycan quaternary ammonium salt hemorrhoid biology long acting antibiotic gel clinical observation on the therapeutic effect obtained in embodiment 6
1 case scenario
Statistics outpatient service and inpatient, observe hemorrhoid patients 98, average age 42 years old altogether.Patient has different degrees of anus It is swollen red, to have blood in stool, severe pain symptom, clinical diagnosis is hemorrhoid.Patient is randomly divided into two groups, test group is used obtained in embodiment 6 Glycosaminoglycan quaternary ammonium salt hemorrhoid biology long acting antibiotic gel, control group uses commercially available MAYINGLONGZHICHUANGGAO.
2 efficacy assessment standards
Cure:Symptom, sign disappear or basic disappearance, and integration reduces >=95%.
It is effective:Symptom, sign are obviously improved, and integration reduces >=70%.
Effectively:Symptom, sign take a favorable turn, and integration reduces >=30%.
It is invalid:Symptom, sign are not improved or aggravate, and integration reduces < 30%.
Computing formula:[(Integrated after integration-treatment before treatment)Integration before ÷ treatments] × 100%.
3 clinical observation results
Glycosaminoglycan quaternary ammonium salt hemorrhoid biology long acting antibiotic gel clinical efficacy contrast table prepared by 7 embodiment of table 6
Data above shows:Glycosaminoglycan quaternary ammonium salt hemorrhoid biology long acting antibiotic gel prepared by the present invention is evident in efficacy higher than city Sell MAYINGLONGZHICHUANGGAO, p < 0.01.

Claims (10)

1. a kind of glycosaminoglycan quaternary ammonium salt solution with antibacterial activity, it is characterized in that taking 2,3 epoxypropyltrimethylchloride chlorides 50 parts, put in reactor, add 100 parts of 30% sodium hydroxide solution, stir 1 hour, be made 2,3 epoxypropyl trimethylammonium chlorides Ammonium salt solution;8 parts of glycosaminoglycan is taken, is put in high-pressure magnetic reactor, add 40 parts of isopropanol, 1 part of Magnesiumaluminumsilicate, 1 part of calcium chloride, Stirring 1 hour, adds above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, selects magnetic force power 1600W, is warming up to 75~85 DEG C, react 1 hour, add 10% hydrochloric acid to adjust pH value to 7.0, suction filtration, filter cake adds 100 parts of absolute ethyl alcohol, reacts 1 hour, with cutting Dialysis membrane that molecular weight is 300000 is stayed to purify, product substitution value is 99%, spin concentration, plus purified water is made mass concentration and is 0.010%~10% glycosaminoglycan quaternary ammonium salt solution.
2. the preparation method of solution according to claim 1, it is characterized in that 50 parts of 2,3 epoxypropyltrimethylchloride chloride is taken, Put in reactor, add 100 parts of 30% sodium hydroxide solution, stir 1 hour, be made 2,3 epoxypropyltrimethylchloride chlorides molten Liquid;8 parts of glycosaminoglycan is taken, is put in high-pressure magnetic reactor, add 40 parts of isopropanol, 1 part of Magnesiumaluminumsilicate, 1 part of calcium chloride, stirring 1 hour, above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution is added, select magnetic force power 1600W, be warming up to 75~85 DEG C, instead Answer 1 hour, add 10% hydrochloric acid to adjust pH value to 7.0, suction filtration, filter cake adds 100 parts of absolute ethyl alcohol, reacts 1 hour, with retention point Son amount is purified for 300000 dialysis membrane, and product substitution value is 99%, and spin concentration, plus purified water is made mass concentration and is 0.010%~10% glycosaminoglycan quaternary ammonium salt solution.
3. a kind of glycosaminoglycan quaternary ammonium salt nasal wash with antibacterial activity, it is characterized in that taking 2,3 epoxies 50 parts of ammonium chloride, puts in reactor, adds 100 parts of 30% sodium hydroxide solution, stirs 1 hour, is made 2,3 glycidyl front threes Ammonium chloride solution;8 parts of glycosaminoglycan is taken, is put in high-pressure magnetic reactor, add 40 parts of isopropanol, 1 part of Magnesiumaluminumsilicate, chlorination 1 part of calcium, stirs 1 hour, adds above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, selects magnetic force power 1600W, is warming up to 75~85 DEG C, react 1 hour, add 10% hydrochloric acid to adjust pH value to 7.0, suction filtration, filter cake adds 100 parts of absolute ethyl alcohol, and reaction 1 is small When, to be purified with the dialysis membrane that molecular cut off is 300000, product substitution value is 99%, and spin concentration, plus purified water is made quality Concentration is 0.010%~10% glycosaminoglycan quaternary ammonium salt solution, is poured into feeder, is made glycosaminoglycan quaternary ammonium salt nasal douche Liquid.
4. a kind of glycosaminoglycan quaternary ammonium salt oral cavity flushing washing lotion with antibacterial activity, it is characterized in that taking 2,3 epoxies 50 parts of ammonium chloride, puts in reactor, adds 100 parts of 30% sodium hydroxide solution, stirs 1 hour, is made 2,3 glycidyl front threes Ammonium chloride solution;8 parts of glycosaminoglycan is taken, is put in high-pressure magnetic reactor, add 40 parts of isopropanol, 1 part of Magnesiumaluminumsilicate, chlorination 1 part of calcium, stirs 1 hour, adds above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, selects magnetic force power 1600W, is warming up to 75~85 DEG C, react 1 hour, add 10% hydrochloric acid to adjust pH value to 7.0, suction filtration, filter cake adds 100 parts of absolute ethyl alcohol, and reaction 1 is small When, to be purified with the dialysis membrane that molecular cut off is 300000, product substitution value is 99%, and spin concentration, plus purified water is made quality Concentration is 0.010%~10% glycosaminoglycan quaternary ammonium salt solution, is poured into feeder, is made glycosaminoglycan quaternary ammonium salt dentilave Liquid.
5. a kind of glycosaminoglycan quaternary ammonium salt vaginal douche with antibacterial activity, it is characterized in that taking 2,3 epoxies 50 parts of ammonium chloride, puts in reactor, adds 100 parts of 30% sodium hydroxide solution, stirs 1 hour, is made 2,3 glycidyl front threes Ammonium chloride solution;8 parts of glycosaminoglycan is taken, is put in high-pressure magnetic reactor, add 40 parts of isopropanol, 1 part of Magnesiumaluminumsilicate, chlorination 1 part of calcium, stirs 1 hour, adds above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, selects magnetic force power 1600W, is warming up to 75~85 DEG C, react 1 hour, add 10% hydrochloric acid to adjust pH value to 7.0, suction filtration, filter cake adds 100 parts of absolute ethyl alcohol, and reaction 1 is small When, to be purified with the dialysis membrane that molecular cut off is 300000, product substitution value is 99%, and spin concentration, plus purified water is made quality Concentration is 0.010%~10% glycosaminoglycan quaternary ammonium salt solution, is poured into feeder, is made glycosaminoglycan quaternary ammonium salt Vaginal lavages Liquid.
6. a kind of glycosaminoglycan quaternary ammonium salt woman with antibacterial activity uses filling gel, it is characterized in that taking 2,3 glycidyl front threes 50 parts of ammonium chloride, puts in reactor, adds 100 parts of 30% sodium hydroxide solution, stirs 1 hour, is made 2,3 glycidyl three Methyl chloride ammonium salt solution;8 parts of glycosaminoglycan is taken, is put in high-pressure magnetic reactor, add 40 parts of isopropanol, 1 part of Magnesiumaluminumsilicate, chlorine Change 1 part of calcium, stir 1 hour, add above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, select magnetic force power 1600W, heat up To 75~85 DEG C, react 1 hour, add 10% hydrochloric acid to adjust pH value to 7.0, suction filtration, filter cake adds 100 parts of absolute ethyl alcohol, reaction 1 Hour, to be purified with the dialysis membrane that molecular cut off is 300000, product substitution value is 99%, and spin concentration, plus purified water is made matter Amount concentration is 1%~10% glycosaminoglycan quaternary ammonium salt gel, is poured into feeder, is made glycosaminoglycan quaternary ammonium salt woman solidifying with filling Glue.
7. a kind of glycosaminoglycan quaternary ammonium salt with antibacterial activity disappears hemorrhoid gel, it is characterized in that taking 2,3 epoxy chlorine Change 50 parts of ammonium, put in reactor, add 100 parts of 30% sodium hydroxide solution, stir 1 hour, be made 2,3 epoxies Ammonium chloride solution;8 parts of glycosaminoglycan is taken, is put in high-pressure magnetic reactor, add 40 parts of isopropanol, 1 part of Magnesiumaluminumsilicate, calcium chloride 1 part, stir 1 hour, add above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, select magnetic force power 1600W, be warming up to 75 ~85 DEG C, react 1 hour, add 10% hydrochloric acid to adjust pH value to 7.0, suction filtration, filter cake adds 100 parts of absolute ethyl alcohol, reacts 1 hour, Purified with the dialysis membrane that molecular cut off is 300000, product substitution value is 99%, spin concentration, plus purified water to be made quality dense The glycosaminoglycan quaternary ammonium salt gel for 1%~10% is spent, in pouring into feeder, glycosaminoglycan quaternary ammonium salt is made and is disappeared hemorrhoid gel.
8. a kind of glycosaminoglycan quaternary ammonium salt skin washing solutions with antibacterial activity, it is characterized in that taking 2,3 epoxies 50 parts of ammonium chloride, puts in reactor, adds 100 parts of 30% sodium hydroxide solution, stirs 1 hour, is made 2,3 glycidyl front threes Ammonium chloride solution;8 parts of glycosaminoglycan is taken, is put in high-pressure magnetic reactor, add 40 parts of isopropanol, 1 part of Magnesiumaluminumsilicate, chlorination 1 part of calcium, stirs 1 hour, adds above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution, selects magnetic force power 1600W, is warming up to 75~85 DEG C, react 1 hour, add 10% hydrochloric acid to adjust pH value to 7.0, suction filtration, filter cake adds 100 parts of absolute ethyl alcohol, and reaction 1 is small When, to be purified with the dialysis membrane that molecular cut off is 300000, product substitution value is 99%, and spin concentration, plus purified water is made quality Concentration is 0.010%~10% glycosaminoglycan quaternary ammonium salt solution, is poured into feeder, is made the flushing of glycosaminoglycan quaternary ammonium salt skin Liquid.
9. a kind of glycosaminoglycan quaternary ammonium salt flushing liquor with antibacterial activity, it is characterized in that taking 2,3 epoxypropyl trimethylammonium chlorides 50 parts of ammonium, puts in reactor, adds 100 parts of 30% sodium hydroxide solution, stirs 1 hour, is made 2,3 epoxy chlorine Change ammonium salt solution;8 parts of glycosaminoglycan is taken, is put in high-pressure magnetic reactor, add 40 parts of isopropanol, 1 part of Magnesiumaluminumsilicate, calcium chloride 1 Part, stir 1 hour, above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution is added, magnetic force power 1600W is selected, it is warming up to 75~ 85 DEG C, react 1 hour, add 10% hydrochloric acid to adjust pH value to 7.0, suction filtration, filter cake adds 100 parts of absolute ethyl alcohol, reacts 1 hour, uses Molecular cut off is 300000 dialysis membrane purifying, and product substitution value is 99%, and spin concentration, plus purified water is made mass concentration It is 0.010%~10% glycosaminoglycan quaternary ammonium salt solution, pours into feeder, is made glycosaminoglycan quaternary ammonium salt flushing liquor.
10. a kind of clean intestinal juice of glycosaminoglycan quaternary ammonium salt with antibacterial activity, it is characterized in that taking 2,3 epoxypropyl trimethylammonium chlorides 50 parts of ammonium, puts in reactor, adds 100 parts of 30% sodium hydroxide solution, stirs 1 hour, is made 2,3 epoxy chlorine Change ammonium salt solution;8 parts of glycosaminoglycan is taken, is put in high-pressure magnetic reactor, add 40 parts of isopropanol, 1 part of Magnesiumaluminumsilicate, calcium chloride 1 Part, stir 1 hour, above-mentioned 2,3 epoxypropyltrimethylchloride chloride solution is added, magnetic force power 1600W is selected, it is warming up to 75~ 85 DEG C, react 1 hour, add 10% hydrochloric acid to adjust pH value to 7.0, suction filtration, filter cake adds 100 parts of absolute ethyl alcohol, reacts 1 hour, uses Molecular cut off is 300000 dialysis membrane purifying, and product substitution value is 99%, and spin concentration, plus purified water is made mass concentration It is 0.010%~10% glycosaminoglycan quaternary ammonium salt solution, pours into feeder, is made the clean intestinal juice of glycosaminoglycan quaternary ammonium salt.
CN201710009683.0A 2017-01-06 2017-01-06 A kind of glycosaminoglycan quaternary ammonium salt solution and preparation method thereof with antibacterial activity Active CN106727671B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710009683.0A CN106727671B (en) 2017-01-06 2017-01-06 A kind of glycosaminoglycan quaternary ammonium salt solution and preparation method thereof with antibacterial activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710009683.0A CN106727671B (en) 2017-01-06 2017-01-06 A kind of glycosaminoglycan quaternary ammonium salt solution and preparation method thereof with antibacterial activity

Publications (2)

Publication Number Publication Date
CN106727671A true CN106727671A (en) 2017-05-31
CN106727671B CN106727671B (en) 2019-02-12

Family

ID=58950989

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710009683.0A Active CN106727671B (en) 2017-01-06 2017-01-06 A kind of glycosaminoglycan quaternary ammonium salt solution and preparation method thereof with antibacterial activity

Country Status (1)

Country Link
CN (1) CN106727671B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107456509A (en) * 2017-08-30 2017-12-12 海南鸿昇生物药械有限公司 A kind of external application biological agent and preparation method for vagina prevention, health care and treatment gynaecology genital inflammation
CN109692583A (en) * 2017-10-20 2019-04-30 中国石油化工股份有限公司 Antibacterial type dry film and its preparation method and application

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104163876A (en) * 2014-08-25 2014-11-26 吉林君同行生物科技有限公司 Chitosan quaternary ammonium salt product and preparation method thereof
CN104887697A (en) * 2015-05-26 2015-09-09 吉林君同行生物科技有限公司 Glycosaminoglycan quaternary ammonium salt composition and application and preparation thereof
CN105664239A (en) * 2016-03-23 2016-06-15 成都交大麦迪克科技有限公司 Preparation method of self-adhesive skin repairing hydrogel

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104163876A (en) * 2014-08-25 2014-11-26 吉林君同行生物科技有限公司 Chitosan quaternary ammonium salt product and preparation method thereof
CN104887697A (en) * 2015-05-26 2015-09-09 吉林君同行生物科技有限公司 Glycosaminoglycan quaternary ammonium salt composition and application and preparation thereof
CN105664239A (en) * 2016-03-23 2016-06-15 成都交大麦迪克科技有限公司 Preparation method of self-adhesive skin repairing hydrogel

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107456509A (en) * 2017-08-30 2017-12-12 海南鸿昇生物药械有限公司 A kind of external application biological agent and preparation method for vagina prevention, health care and treatment gynaecology genital inflammation
CN109692583A (en) * 2017-10-20 2019-04-30 中国石油化工股份有限公司 Antibacterial type dry film and its preparation method and application

Also Published As

Publication number Publication date
CN106727671B (en) 2019-02-12

Similar Documents

Publication Publication Date Title
CN104163876B (en) Chitosan quaternary ammonium product salt and preparation method thereof
RU2303039C2 (en) Water-soluble iron-carbohydrate complexes, method for their preparing, medicinal agent, using
JP2002521054A (en) Carrageenan compositions and methods for their manufacture
CN102824308A (en) Chitosan antibacterial filming sprayer and preparation method
JP5507609B2 (en) Peritoneal dialysate
JP2004323453A (en) Decomposable gel and method for producing the same
CN104208726B (en) Chitosan quaternary ammonium salt couplant and preparation method thereof
CN101011606A (en) Anti-sticking flush fluid
CN106727671A (en) A kind of glycosaminoglycan quaternary ammonium salt solution with antibacterial activity and preparation method thereof
JP4321007B2 (en) Polysaccharide complex and method for producing the same
TWI240630B (en) Buffered compositions for dialysis
CN105504087B (en) The preparation method of medical grade calcium alginate
CN101584889B (en) External in-situ forming matrix used for treating periodontal diseases
JP3253982B2 (en) Acne cosmetics
CN106963729B (en) It is a kind of to be used to prevent pharmaceutical preparation of operative hemorrhage and preparation method thereof
CN100398112C (en) Medicine for treating hyperphosphatemia and its preparing method
TWI253931B (en) Sebum production inhibitors
CN104721845B (en) A kind of disinfection sterilizing type medical supersonic couplant for having moisturizing and moisturizing effect concurrently and preparation method thereof
KR101895950B1 (en) Composition for treating osteoarthritis comprising hydrophilized sulfasalazine and hyaluronic acid and method for preparing the same
ES2290195T3 (en) USE OF CARBON HYDRATES TO ELIMINATE INTESTINAL INFECTIONS IN ANIMALS.
JP3884611B2 (en) Improving agent for impulsive disease
RU2280041C1 (en) Method for preparing water-soluble saline complexes of hyaluronic acid (variants)
JP2000038342A (en) Pharmaceutical preparation for restoring bedsore and damaged skin
JP2012526173A (en) Novel sulfated octasaccharide and its use as an antithrombotic agent
CN102755663A (en) Formula of medical biocolloid solution and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant